Author: Minichart

us corporate news

SCYNEXIS Acquires PXL-770 (SCY-770) to Advance Innovative ADPKD Therapy with Phase 2 Trial Planned for 2026

Minichart

March 31, 2026

SCYNEXIS Acquires PXL-770 (SCY-770) for ADPKD: Key Investor ...

Continue Reading 0

us corporate news

TD SYNNEX Reports Record Q1 2026 Results: Revenue Surges 18%, Non-GAAP EPS Up 69%, Raises Dividend

Minichart

March 31, 2026

TD SYNNEX Delivers Record Q1 FY2026 Results: Surging Revenue...

Continue Reading 0

us corporate news

SCYNEXIS Announces $40 Million Private Placement to Fund SCY-770 Development for Rare Kidney Disease

Minichart

March 31, 2026

SCYNEXIS Announces \$40 Million Private Placement to Advance...

Continue Reading 0

us corporate news

Xtant Medical Achieves Profitability and 14% Revenue Growth in 2025, Provides 2026 Outlook After Strategic Divestiture

Minichart

March 31, 2026

Xtant Medical (XTNT) Reports Q4 and Full-Year 2025 Financial...

Continue Reading 0

us corporate news

Tonix Pharmaceuticals Presents Phase 1 Data for TNX-4800, a Long-Acting Monoclonal Antibody for Lyme Disease Prevention, and Plans Adaptive Phase 2 Field Study

Minichart

March 31, 2026

Tonix Pharmaceuticals Announces Positive Phase 1 Data and Ph...

Continue Reading 0

us corporate news

AlTi Global Reports $93 Billion AUM and Strong UHNW Wealth Management Growth in Q4 2025 Earnings

Minichart

March 31, 2026

AlTi Global, Inc. Reports Strong FY2025 Earnings Growth, Str...

Continue Reading 0

us corporate news

Charlotte’s Web Reports 2025 Financial Results – CMMI Medicare CBD Pilot Participation and Regulatory Momentum Position Company for Growth

Minichart

March 31, 2026

Charlotte’s Web Holdings, Inc. – 2025 Fourth Quarter and Ful...

Continue Reading 0

us corporate news

Willis Lease Finance Corp 8-K SEC Filing Details for March 26, 2026: Company Information & NASDAQ Listing

Minichart

March 31, 2026

Willis Lease Finance Corp Announces Termination of Major Cre...

Continue Reading 0

us corporate news

Scholar Rock Resubmits Apitegromab BLA to FDA for Spinal Muscular Atrophy Treatment, Anticipates Approval in Late 2026 123

Minichart

March 31, 2026

Scholar Rock Resubmits BLA for Apitegromab: Key Investor Ins...

Continue Reading 0

us corporate news

Odysight.ai Announces Dual Listing on Tel Aviv Stock Exchange to Expand Investor Base and Enhance Trading Liquidity 1

Minichart

March 31, 2026

Odysight.ai Announces Dual Listing on Tel Aviv Stock Exchang...

Continue Reading 0